相关实验视频

Updated: Jun 16, 2025

TAPE: A Biodegradable Hemostatic Glue Inspired by a Ubiquitous Compound in Plants for Surgical Application

TAPE: A Biodegradable Hemostatic Glue Inspired by a Ubiquitous Compound in Plants for Surgical Application

Published on: June 8, 2016

流动凝血静电矩阵的剂量比较,用于初级膝关节关节整形术中的出血损失

Shogo Matsuda¹, Masashi Miyazaki², Masashi Hirakawa²

¹Orthopedic Surgery, Oita University, Yufu, JPN.

|August 19, 2024

概括

这项研究发现,使用可流凝静血矩阵 (FGHM) 进行全膝关节关节整形术 (TKA) 后,出血没有显著减少. 需要进一步的研究来澄清FGHM在TKA患者的临床效用.

科学领域:

整形外科手术整形外科手术
手术性静血静血是指手术性静血
生物材料是一种生物材料.

背景情况:

在全膝关节整形术 (TKA) 中,手术内和手术后出血是很重要的问题,可能会影响患者的治疗结果.
一种可流动的等血静止矩阵 (FGHM) 在各种外科领域使用,但其在TKA中的有效性仍在争论中.

研究的目的:

为了评估不同剂量的FGHM在减少初级TKA后的血液损失方面的有效性.
为了比较对照组和FGHM治疗组之间的总血红蛋白损失,排水量,隐藏的血液损失和计算的总血液损失.

主要方法:

一项前性研究涉及122名接受单边初级TKA的患者.
患者被分为三个组:对照组 (没有FGHM),5毫升FGHM和8毫升FGHM.
关键的结果措施包括血红蛋白损失,排水量,隐性血液损失,总血液损失,术后曲和深静脉血栓 (DVT) 发生率.

主要成果:

在手术后的第1天或第7天,在三个组之间没有观察到总血红蛋白损失,排水量或隐藏血液损失的统计学上显著差异.
较高FGHM剂量下降计算总血液损失的趋势被注意到,但没有达到统计学意义.
手术后曲角度和DVT发病率在各组之间没有显著差异.

结论:

虽然FGHM观察到减少出血的趋势,但它在初级TKA中没有达到统计学意义.
目前的研究无法确定FGHM对减轻该患者群体的血液损失的临床效用.
需要进一步调查,以确定FGHM在TKA后的血液损失管理中的作用.

关键词:

控制出血控制出血血红蛋白血红蛋白是一个血静剂是一种血静剂.总体失去的血液总量.整体膝关节关节整形手术

更多相关视频

Preparation, Procedures and Evaluation of Platelet-Rich Plasma Injection in the Treatment of Knee Osteoarthritis

Preparation, Procedures and Evaluation of Platelet-Rich Plasma Injection in the Treatment of Knee Osteoarthritis

Published on: January 4, 2019

Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow

Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow

Published on: March 5, 2020

相关概念视频

Introduction to Hemostasis

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...

Formation of the Platelet Plug

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...